Reactive nitrogen species, reactive oxygen species, transition metal ions, and the vascular system

Pharmaceutical Research

Volumn 13, Issue 5, 1996, Pages 649-662

  Darley Usmar, Victor ^a   Halliwell, Barry ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Nitric oxide; Oxidative stress; Oxygen radical; Peroxynitrite; Reactive nitrogen species; Vascular system

Indexed keywords

OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; ANIMAL; ARTERIOSCLEROSIS; BLOOD; HUMAN; LIPID PEROXIDATION; METABOLISM; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANTIOXIDANT; FREE RADICAL; METAL; NITRIC OXIDE; NITROGEN; REACTIVE OXYGEN METABOLITE;

ANIMALS; ANTIOXIDANTS; ARTERIOSCLEROSIS; ENDOTHELIUM, VASCULAR; FREE RADICALS; HUMANS; LIPID PEROXIDATION; METALS; NITRIC OXIDE; NITROGEN; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 0030133352     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016079012214     Document Type: Review

References (194)

1. B. Halliwell and JMC Gutteridge. Free Radicals in Biology and Medicine, ed. 2 Clarendon Press, Oxford, 1989.
2. S. Moncada and A. Higgs. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J. 9:1319-1330 (1995).
3. I. Fridovich. Superoxide dismutases: An adaptation to a paramagnetic gas. J. Biol. Chem. 264:7761-7764 (1989).
4. J. T. Curnutte and B. M. Babior. Chronic granulomatous disease. Adv. Hum. Genet. 16:229-297 (1987).
5. G. A. C. Murrell, M. J. O. Francis, and L. Bromley. Modulation of fibroblast proliferation by oxygen free radicals. Biochem. J. 265:659-665 (1990).
6. B. Meier, H. Radeke, S. Selle, H. H. Raspe, G. Sies, K. Resch, and G. G. Habermehl. Human fibroblasts release reactive oxygen species in response to treatment with synovial fluids from patients suffering from arthritis. Free. Rad. Res. Commun. 8:149-160 (1990).
7. F. E. Maly. The B-lymphocyte: A newly-recognized source of reactive oxygen species with immunoregulatory potential. Free. Rad. Res. Commun. 8:143-148 (1990).
8. P. R. Gardner and I. Fridovich. Inactivation-reactivation of aconitase in Escherichia coli. A sensitive measure of superoxide radical. J. Biol. Chem. 267:8757-8763 (1992).
9. Y. Zhang, O. Marcillat, C. Giulivi, L. Ernster, and K. J. A. Davies. The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J. Biol. Chem. 265:16330-16336 (1990).
10. M. Lepoivre, J. M. Flaman, P. Bobé, G. Lemaire, and Y. Henry. Quenching of the tyrosyl free radical of ribonucleotide reductase by nitric oxide. J. Biol. Chem. 269:21891-21897 (1994).
11. M. W. J. Cleeter, J. M. Cooper, V. M. Darley-Usmar, S. Moncada, and A. H. V. Schapira. Reversible inhibition of cytochrome c oxidase the terminal enzyme of the mitochondrial respiratory chain by nitric oxide. FEBS Lett. 345:50-54 (1994).
12. L. Castro, M. Rodriguez, and R. Radi. Aconitase is readily inactivated by peroxynitrite but not by its precursor nitric oxide. J. Biol. Chem. 269:29409-29415 (1994).
13. R. Radi, M. Rodriguez, L. Castro, and R. Telleri. Inhibition of mitochondrial electron transport by peroxynitrite. Arch. Biochem. Biophys. 303:89-95 (1994).
14. M. A. Packer, and M. P. Murphy. Peroxynitrite causes calcium efflux from mitochondria which is prevented by cyclosporin A. FEBS Lett. 345:237-240 (1994).
15. C. von Sonntag. The Chemical Basis of Radiation Biology. Taylor & Francis, London, 1987.
16. B. Halliwell, and J. M. C. Gutteridge. Role of free radicals and catalytic metal ions in human disease. Methods Enzymol. 186:1-85 (1990).
17. L. P. Candeias, K. B. Patel, M. R. L. Stratford, and P. Wardman. Free hydroxyl radicals are formed on reaction between the neutrophil-derived species superoxide an ion and hypochlorous acid. FEBS Lett. 333:151-153 (1993).
18. B. Demple, and L. Harrison. Repair of oxidative damage to DNA: enzymology and biology. Annu. Rev. Biochem. 63:915-948 (1994).
19. T. Grune, T. Reinheckel, M. Joshi, and K. J. A. Davies. Proteolysis in cultured liver epithelial cells during oxidative stress. J. Biol. Chem. 270:2344-2351 (1995).
20. W. O. Carter, P. K. Narayanan, and J. P. Robinson. Intracellular hydrogen peroxide and superoxide anion detected in endothelial cells. J. Leukoc. Biol. 55:253-258 (1994).
21. W. Yang, and E. R. Block. Effect of hypoxia and reoxygenation on the formation and release of reactive oxygen species by porcine pulmonary artery endothelial cells. J. Cell Physiol. 164:414-423 (1995).
22. C. F. Babbs, M. D. Cregor, J. J. Turek, and S. F. Badylak. Endothelial superoxide production in buffer perfused rat lungs, demonstrated by a new histochemical technique. Lab. Invest. 65:484-496 (1991).
23. B. E. Britigan, T. L. Roeder, and D. M. Shasby. Insight into the nature and site of oxygen-centered free radical generation by endothelial cell monolayers using a novel spin trapping technique. Blood 79:699-707 (1992).
24. L. S. Terada, I. R. Willingham, M. E. Rosandich, J. A. Leff, G. W. Kindt, and J. E. Repine. Generation of superoxide anion by brain endothelial cell xanthine oxidase. J. Cell Physiol. 184:191-196 (1991).
25. T. Sundqvist. Bovine aortic endothelial cells release hydrogen peroxide. J. Cell Physiol. 148:152-156 (1991).
26. C. M. Arroyo, A. J. Carmichael, B. Bouscarel, J. H. Liang, and W. B. Weglicki. Endothelial cells as a source of oxygen-free radicals: An ESR study. Free Rad. Res. Commun. 9:287-296 (1990).
27. R. E. Ratych, R. S. Chuknyiska, and G. B. Bulkley. The primary localization of free radical generation after anoxia/reoxygenation in isolated endothelial cells. Surgery 102:122-126 (1987).
28. M. L. Schinetti, R. Sbarbati, and M. Scarlattini. Superoxide production by human umbilical vein endothelial cells in an anoxiareoxygenation model. Cardiovasc. Res. 23:76-79 (1989).
29. T. Matsubara, and M. Ziff. Increased superoxide anion release from human endothelial cells in response to cytokines. J. Immunol. 137:3295-3299 (1986).
30. Y. Hashimoto, K. Itoh, K. Nishida, T. Okano, Y. Miyazawa, and K. Okinaga. Rapid superoxide production by endothelial cells and their injury upon reperfusion. J. Surg. Res. 57:693-697 (1994).
31. Y. Ohara, T. E. Peterson, H. S. Sayegh, R. R. Subramanian, J. N. Wilcox, and D. G. Harrison. Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production. Circulation 92:898-903 (1995).
32. J. L. Zweier, R. Broderick, P. Kuppusamy, S. Thompson-Gorman, and G. A. Lutty. Determination of the mechanism of free radical generation in human aortic endothelial cells exposed to anoxia and reoxygenation. J. Biol. Chem. 269:24156-24162 (1994).
33. A. Paler-Martinez, P. C. Panus, P. H. Chumley, U. Ryan, M. M. Hardy, and B. A. Freeman. Endogenous xanthine oxidase does not significantly contribute to vascular endothelial production of reactive oxygen species. Arch. Biochem. Biophys. 311:79-85 (1994).
34. K. M. Mohazzab-h, P. W. Kaminski, and M. S. Wolin. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am. J. Physiol. 266:H2568-H2572 (1994).
35. P. J. Pagano, Y. Ito, K. Tornheim, P. M. Gallop, A. I. Tauber, and R. A. Cohen. An NADPH oxidase superoxide-generating system in the rabbit aorta. Am. J. Physiol. 268:H2274-H2280 (1995).
36. J. J. Zulueta, F. S. Yu, I. A. Hertig, V. J. Thannickal, and P. M. Hassoun. Release of hydrogen peroxide in response to hypoxiareoxygenation: Role of an NAD(P)H oxidase-like enzyme in endothelial cell plasma membrane. Am. J. Resp. Cell. Mol. Biol. 12:41-49 (1995).
37. D. A. Parks, Y. Yokoyama, S. Tan, E. Dickens, T. G. Cash and B. A. Freeman. Xanthine oxidase in the circulation of rats following hemorrhagic shock. Free Rad. Biol. Med. 15:407-414 (1993).
38. R. Miesel and M. Zuber. Elevated levels of xanthine oxidase in serum of patients with inflammatory and autoimmune rheumatic diseases. Inflammation 17:551-561 (1993).
39. S. Tan, S. Gelman, J. K. Wheat, and D. A. Parks. Circulating xanthine oxidase in human ischemia reperfusion. Southern Med. J. 88:479-482 (1995).
40. R. E. Huie, and S. Padmaja. The reaction of NO with superoxide. Free Rad. Res. Commun. 18:195-199 (1993).
41. W. W. Kooy, and J. A. Royal. Agonist-induced peroxynitrite production from endothelial cells. Arch. Biochem. Biophys. 310:352-359 (1994).
42. K. Nakazono, N. Watanabe, K. Matsuno, J. Sasaki, T. Sato, and M. Inoue. Does superoxide underlie the pathogenesis of hypertension? Proc. Natl. Acad. Sci. USA 88:10045-10048 (1991).
43. F. R. M. Laurindo, P. L. de Luz, L. Uint, T. F. Rocha, and R. G. Jaeger. Evidence for superoxide radical-dependent coronary vasospasm after angioplasty in intact dogs. Circulation 83:1705-1715 (1991).
44. J. S. Beckman, J. Chen, H. Ischiropoulous, and J. P. Crow. Oxidative chemistry of peroxynitrite. Meth. Enzymol. 233:229-240 (1994).
45. J. S. Beckman, T. W. Beckman, J. Chen, P. A. Marshall, and B. A. Freeman. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA. 87:1620-1624 (1990).
46. A. van der Vliet, C. A. O'Neill, B. Halliwell, C. E. Cross and H. Kaur. Aromatic hydroxylation and nitration of phenylalanine and tyrosine by peroxynitrite. FEBS Lett. 339:89-92 (1994).
47. M. A. Moro, V. M. Darley-Usmar, I. Lizasoain, Y. Su, R. G. Knowles, M. W. Radomski, and S. M. Moncada. The formation of nitric oxide donors from peroxynitrite. Brit. J. Pharmacol. 116:1999-2004.
48. M. A. Moro, V. M. Darley-Usmar, D. A. Goodwin, N. G. Read, R. Zamora-Pino, M. Feelish, M. Radomski, and S. Moncada. Paradoxical fate and biological action of peroxynitrite on human platelets. Proc. Natl. Acad. Sci. USA 91:6702-6706 (1994).
49. T. Abrahamsson, U. Brandt, S. L. Marklund, and P. O. Sjöqvist. Vascular bound recombinant extracellular superoxide dismutase type C protects against the detrimental effects of superoxide radicals on endothelium-dependent arterial relaxation. Circ. Res. 70:264-271 (1992).
50. L. M. Carlsson, J. Jonsson, T. Edlund, and S. L. Marklund. Mice lacking extracellular superoxide dismutase are more sensitive to hyperoxia. Proc. Natl. Acad. Sci. USA 92:6264-6268 (1995).
51. L. Jornot, and A. F. Junod. Variable glutathione levels and expression of antioxidant enzymes in human endothelial cells. Am. J. Physiol. 264:L482-L489 (1993).
52. A. Verkerk, and J. F. Jongkind. Vascular cells under peroxide induced oxidative stress: a balance study on in vitro peroxide handling by vascular endothelial and smooth muscle cells. Free Rad. Res. Commun. 17:121-132 (1992).
53. P. A. Hyslop, D. B. Hinshaw, W. A. Halsey JR et al. Mechanisms of oxidant-mediated cell injury. J. Biol. Chem. 263:1665-1675 (1988).
54. J. Varani, M. K. Dame, D. F. Gibbs, C. G. Taylor, J. M. Weinberg, J. Shayevitz, and P. A. Ward. Human umbilical vein endothelial cell killing by activated neutrophils. Lab. Invest. 66:708-714 (1992).
55. P. R. Kvietys, W. Inauen, B. R. Bacon, and M. B. Grisham. Xanthine oxidase-induced injury to endothelium: role of intracellular iron and hydroxyl radical. Am. J. Physiol. 257:H1640-H1646 (1989).
56. B. Halliwell, and J. M. C. Gutteridge. Oxygen-free radicals and iron in relation to biology and medicine: some problems and concepts. Arch. Biochem. Biophys. 246:501-508 (1986).
57. P. Biemond, H. G. Van Eijk, A. J. G. Swaak, and J. F. Koster. Iron mobilization from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes: Possible mechanism in inflammation diseases. J. Clin. Invest. 73:1576-1579 (1984).
58. B. J. Bolann, and R. J. Ulvik. On the limited ability of superoxide to release iron from ferritin. Eur. J. Biochem. 193:899-904 (1990).
59. J. M. C. Gutteridge. Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides. FEBS Lett. 201:291-295 (1986).
60. A. Puppo, and B. Halliwell. Formation of hydroxyl radicals from hydrogen peroxide in the presence of iron: Is haemoglobin a biological Fenton catalyst? Biochem. J. 249:185-190 (1988).
61. M. R. Prasad, R. M. Engelman, R. M. Jones, and D. K. Das. Effects of oxyradicals on myoglobin. Deoxygenation, haem removal and iron release. Biochem. J. 263:731-736 (1989).
62. G. Balla, G. M. Vercellotti, U. Muller-Eberhard, J. Eaton, and H. S. Jacob. Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species. Lab. Invest. 64:648-655 (1991).
63. J. Balla, K. A. Nath, G. Balla, M. B. Juckett, H. S. Jacob, and G. M. Vercellotti. Endothelial cell heme oxygenase and ferritin induction in rat lung by hemoglobin in vivo. Am. J. Physiol. 268:L321-L327 (1995).
64. N. G. Abraham, Y. Lavrovsky, M. L. Schwartzman, R. A. Stoltz, R. D. Levere, M. E. Gerritsen, S. Shibahara, and A. Kappas. Transfection of the human heme oxygenase gene into rabbit coronary microvessel endothelial cells: protective effect against heme and hemoglobin toxicity. Proc. Natl. Acad. Sci. USA 92:6798-6802 (1995).
65. B. Halliwell, J. M. C. Gutteridge, and C. E. Cross. Free radicals, antioxidants and human disease: Where are we now? J. Lab. Clin. Med. 119:598-620 (1992).
66. B. Halliwell, O. I. Aruoma, G. Mufti, and A. Bomford. Bleomycindetectable iron in serum from leukaemic patients before and after chemotherapy. Therapeutic implications for treatment with oxidant-generating drugs. FEBS Lett. 241:202-204 (1988).
67. J. M. C. Gutteridge, P. G. Winyard, D. R. Blake, J. Lunec, S. Brailsford, and B. Halliwell. The behaviour of caeruloplasmin in stored human extracellular fluids in relation to ferroxidase II activity, lipid peroxidation, and phenanthroline-detectable copper. Biochem. J. 230:517-523 (1985).
68. P. J. Evans, R. W. Evans, A. Bomford, R. Williams, and B. Halliwell. Metal ions catalytic for free radical reactions in the plasma of patients with fulminant hepatic failure. Free Rad. Res. 20:119-133 (1994).
69. J. A. Swain, V. Darley-Usmar, and J. M. C. Gutteridge. Peroxynitrite releases copper from caeruloplasmin: implications for atherosclerosis. FEBS Lett. 342:49-52 (1994).
70. V. O'Donnell, and M. J. Burkitt. Mitochondrial metabolism of a hydroperoxide to free radicals in human endothelial cells; an electron spin resonance spin-trapping study. Biochem. J. 304:704-713 (1994).
71. S. Yla-Herttuala, W. Palinski, M. E. Rosenfield, S. Parthasarathy, T. E. Carew, S. Butler, J. L. Witztum and D. Steinberg. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84:1086-1099 (1989).
72. W. Palinski, M. E. Rosenfeld, S. Yla-Herttuala, G. C. Gurtner, S. S. Socher, S. W. Butler, S. Parthasarathy, T. E. Carew, D. Steinberg and J. L. Witztum. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA 86:1372-1376 (1989).
73. M. E. Haberland, C. L. Olch and A. M. Fogelman. Role of lysines in mediating interaction of modified low density lipoproteins with the scavenger receptor of human monocyte macrophages. J. Biol. Chem. 259:18:11305-11311 (1984).
74. S. Parthasarthy, D. J. Printz, D. Boyd, L. Joy and D. Steinberg. Macrophage oxidation of LDL generates a modified form recognised by the scavenger receptor. Arteriosclerosis 6:505-510 (1986).
75. J. T. Salonen, S. Yla-Herttuala, R. Yamamoto, S. Butler, H. Korpela, R. Salonen, K. Nyyssonen, W. Palinski and J. L. Witztum. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 339:883-885 (1992).
76. R. A. Riemersma, D. A. Wood, C. C. A. MacIntyre, R. A. Elton, K. F. Gey, and M. F. Oliver. Risk of angina pectoris and plasma concentrations of vitamins A, C and E and carotene. Lancet 337:1 (1991).
77. F. K. Gey. Ten year retrospective on the antioxidant hypothesis of arteriosclerosis. J. Nutr. Biochem. 6:206-236 (1995).
78. E. B. Rimm, M. J. Stampfer, A. Ascherio, E. Giovannucci, G. A. Colditz and W. C. Willett. Vitamin E consumption and the risk of coronary heart disease in men. N. Engl. J. Med. 328:1450-1456 (1993).
79. M. Dieber-Rotheneder, H. Puhl, G. Waeg, G. Striegl and H. Esterbauer. Effect of oral supplementation with D-α-tocopherol on the α-tocopherol content of human low density lipoproteins and resistance to oxidation. J. Lipid Res. 32:1325-1332 (1991).
80. P. D. Reaven, S. Parthasarathy, W. F. Beltz and J. L. Witztum. Effect of probucol dosage on plasma lipid and lipoprotein levels and on protection of low density lipoprotein against in vitro oxidation in humans. Arteriosclerosis and Thrombosis 12:318-324 (1992).
81. J. Regnstrom, G. Walldius, L. A. Carlson and J. Nilsson. Effect of probucol on the susceptibility of low density lipoprotein isolated from hypercholesterolemic patients to become oxidatively modified in vitro. Atherosclerosis 82:43-51 (1990).
82. E. Maggi, R. Bellazzi, F. Falaschi, A. Frattoni, G. Perani, G. Finardi, A. Gazo, M. Ni, D. Romanini and G. Bellomo. Enhanced LDL oxidation in uremic patients: and additional mechanisms for accelerated atherosclerosis. Kidney Int. 45:876-883 (1994).
83. J. Regnstrom, J. Nilsson, P. Tornvall, C. Landou and A. Hamsten. Susceptibility to low density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 339:1183-1186 (1992).
84. H. Esterbauer, J. Gebicki, H. Puhl and G. Jurgens. The role of lipid peroxidation and antioxidants in the oxidative modification of LDL. Free Rad. Biol. Med. 13:341-390 (1993).
85. P. Reaven, S. Parthasarathy, B. J. Grasse, E. Miller, F. Alonazan, F. H. Mattson, J. C. Khoo, D. Steinberg and J. L. Witztum. Feasibility of using an oleate rich diet to reduce the susceptibility of LDL to oxidative modification in humans. Am. J. Clin. Nutr. 54:701-706 (1991).
86. C. E. Thomas and R. L. Jackson. Lipid hydroperoxide involvement in copper dependent and independent oxidation of low density lipoproteins. J. Pharmacol. Exp. Ther 256:1182-1188 (1991).
87. V. J. O'Leary, V. M. Darley-Usmar, L. J. Russell and D. Stone. Prooxidant effects of lipoxygenase-derived peroxides on the copperinitiated oxidation of low-density lipoprotein. Biochem. J. 282:631-634 (1992).
88. N. Hogg, C. Rice-Evans, V. Darley-Usmar, M. T. Wilson, G. Paganga and L. Bourne. The role of lipid hydroperoxides in the myoglobin-dependent oxidation of LDL. Arch. Biochem. Biophys. 314:39-44 (1994).
89. M. Iwatsuki, E. Niki, D. Stone and V. Darley-Usmar. α-Tocopherol mediated peroxidation in the copper(II) and metmyoglobin induced oxidation of human low density lipoprotein: the influence of lipid hydroperoxides. FEBS Lett. 360:271-276 (1995).
90. B. Frei and J. M. Gaziano. Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human low density lipoprotein to metal-ion dependent and -independent oxidation. J. Lipid. Res. 34:2135-2145 (1993).
91. D. R. Smith, V. J. O'Leary and V. M. Darley-Usmar. The role of α-tocopherol as a peroxyl radical scavenger in human low density lipoprotein. Biochem. Pharmacol. 45:2195-2201 (1993).
92. Y. Yoshida and E. Niki. Oxidation of methyl linoleate in aqueous dispersions induced by copper and iron. Arch. Biochem. Biophys. 295:107-114 (1992).
93. V. A. Folcik, R. Nivar-Aristy, L. P. Krajewski, and M. K. Cathcart. Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques. J. Clin. Invest. 96:504-510 (1995).
94. S. Ylä-Herttuala, J. Luoma, H. Viita, T. Hiltunen, T. Sisto, and T. Nikkari. Transfer of 15-lipoxygenase gene into rabbit iliac arteries results in the appearance of oxidation-specific lipid-protein adducts characteristic of oxidized low density lipoprotein. J. Clin. Invest. 95:2692-2698 (1995).
95. Y. Yoshida, J. Tsuchiya and E. Niki. Interaction of α-tocopherol with copper and its effects on lipid peroxidation. Biochim. Biophys. Acta. 1200:85-92 (1994).
96. V. W. Bowry, D. Mohr, J. Cleary and R. Stocker. Prevention of tocopherol-mediated peroxidation in ubiquinol-10-free human low density lipoprotein. J. Biol. Chem. 270:5756-5763 (1995).
97. K. Mukai, H. Morimoto, Y. Okauchi, and S. Nagaoka. Kinetic study of reactions between tocopheroxyl radicals and fatty acids. Lipids 28:753-756 (1993).
98. H. Esterbauer, R. J. Schaur and H. Zollner. Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Rad. Biol. Med. 11:81-128 (1991).
99. V. M. Darley-Usmar, A. Severn, V. J. O'Leary and M. Rogers. Treatment of macrophages with oxidised low density lipoprotein increases their intracellular glutathione content. Biochem. J. 278:429-434 (1991).
100. N. Gotoh, A. Graham, E. Niki and V. M. Darley-Usmar. Inhibition of glutathione synthesis increases the toxicity of oxidised LDL to human monocytes and macrophages. Biochem. J. 296:151-154 (1993).
101. G. Del Boccio, D. Lapenna, E. Porreca, A. Pennilli, F. Savini, P. Feliciani, G. Ricci and F. Cuccurullo. Aortic antioxidant defence mechanisms: time-related changes in cholesterol fed rabbits. Atherosclerosis 81:127-135 (1990).
102. 2 like compounds are produced in vivo by humans by a non-cyclooxygenase, free radical catalysed mechanism. Proc. Natl. Acad. Sci. USA 87:9383-9387 (1990).
103. 2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation. J. Clin. Invest. 90:2502-2507 (1992).
104. 2-isoprostanes) in the hepatorenal syndrome. J. Lipid Mediat. 6:417-420 (1993).
105. 2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro. J. Clin. Invest. 93:998-1004 (1994).
106. 2-isoprostanes) in smokers. N. Engl. J. Med. 332:1198-1203 (1995).
107. 2-isoprostanes during the oxidation of human low density lipoprotein and plasma by peroxynitrite. Circ. Res. 77:335-341 (1995).
108. B. N. Ames. Endogenous oxidative DNA damage, aging, and cancer. Free Rad. Res. Commun. 7:121-128 (1989).
109. J. R. Totter. Spontaneous cancer and its possible relationship to oxygen metabolism. Proc. Natl. Acad. Sci. USA 77:1763-1767 (1980).
110. B. Halliwell. Free radicals and antioxidants: a personal view. Nutr. Rev. 52:253-265 (1994).
111. H. Sies. Oxidative Stress, Oxidants and Antioxidants, Academic Press, London and New York, 1991.
112. R. C. M. Siow, T. Ishii, H. Sato et al. Induction of the antioxidant stress proteins heme oxygenase-1 and MSP23 by stress agents and oxidized LDL in cultured vascular smooth muscle cells. FEBS Lett. 368:239-242 (1995).
113. 2+ in toxic cell killing. Trends Pharmacol. Sci. 10:281-285 (1989).
114. R. L. Thies and A. P. Autor. Reactive oxygen injury to cultured pulmonary artery endothelial cells: Mediation by poly(ADP-ribose) polymerase activation causing NAD depletion and altered energy balance. Arch. Biochem. Biophys. 286:353-363 (1991).
115. R. G. Spragg. DNA strand break formation following exposure of bovine pulmonary artery and aortic endothelial cells to reactive oxygen products. Am. J. Respir. Cell. Mol. Biol. 4:4-10 (1991).
116. E. R. Block. Hydrogen peroxide alters the physical state and function of the plasma membrane of pulmonary artery endothelial cells. J. Cell. Physiol. 146:362-369 (1991).
117. 2+ and proteolysis in lethal oxidative injury in endothelial cells. Am. J. Physiol. 261:C889-C896 (1991).
118. S. P. Andreoli. Mechanisms of endothelial cell ATP depletion after oxidant injury. Pediat. Res. 25:97-101 (1989).
119. R. A. Kozar, B. J. McKeone, and H. J. Pownall. Free radical-induced alterations in endothelial cell function. J. Surg. Res. 56:32-36 (1994).
120. B. Halliwell, and O. I. Aruoma. DNA damage by oxygen-derived species: Its mechanism and measurement in mammalian systems. FEBS Lett. 281:9-19 (1991).
121. 2+-flux pathways in canine venous endothelial cells. Biochem. J. 297:209-215 (1994).
122. K. D. Patel, G. A. Zimmerman, S. M. Prescott, R. P. McEver, and T. M. McIntyre. Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J. Cell Biol. 112:749-759 (1991).
123. M. A. Shatos, J. M. Doherty, and J. C. Hoak. Alterations in human vascular endothelial cell function by oxygen free radicals. Platelet adherence and prostacyclin release. Arteriosclerosis Thrombosis 11:594-601 (1991).
124. C. Weber, W. Erl, A. Pietsch, M. Strobel, H. W. Ziegler-Heitbrock, and P. C. Weber. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-κB mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. Arteriosclerosis Thrombosis 14:1665-1673 (1994).
125. G. M. Vercellotti, S. P. Severson, P. Duane, and C. F. Moldow. Hydrogen peroxide alters signal transduction in human endothelial cells. J. Lab. Clin. Med. 117:15-24 (1991).
126. S. K. Lo, K. Janakidevi, L. Lai, and S. B. Malik. Hydrogen peroxide-induced increase in endothelial adhesiveness is dependent on ICAM-1 activation. Am. J. Physiol. 264:L406-L412 (1993).
127. V. Natarajan, M. M. Taher, B. Roehm, N. L. Parinandi, H. H. O. Schmid, Z. Kiss, J. G. N. Garcia. Activation of endothelial cell phospholipase D by hydrogen peroxide and fatty acid hydroperoxide. J. Biol. Chem. 268:930-937 (1993).
128. M. S. Lewis, R. E. Whatley, P. Cain, T. M. McIntyre, S. M. Prescott, and G. A. Zimmerman. Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion: J. Clin. Invest. 82:2045-2055 (1988).
129. M. Suzuki, W. Inauen, P. R. Kvietys, M. B. Grisham, C. Meininger, M. E. Schelling, H. J. Granger, D. N. Granger. Superoxide mediates reperfusion-induced leukocyte-endothelial cell interactions. Am. J. Physiol. 257:H1740-H1745 (1989).
130. J. R. Bradley, D. R. Johnson, and J. S. Pober. Endothelial activation by hydrogen peroxide. Am. J. Path. 142:1598-1609 (1993).
131. H. A. Lehr, A. M. Olofsson, T. E. Carew, P. Vajkoczy, U. H. von Andrian, C. Hübner, M. C. Berndt, D. Steinberg, K. Messmer, K. E. Arfors. P-selectin mediates the interaction of circulating leukocytes with platelets and microvascular endothelium in response to oxidized lipoprotein in vivo. Lab. Invest. 71:380-386 (1994).
132. 2 by exogenous hydrogen peroxide. Biochem. Pharmacol. 50:753-761 (1995).
133. C. M. Tan, S. Xenoyannis and R. D. Feldman. Oxidant stress enhances adenylyl cyclase activation. Circ. Res. 77:710-717 (1995).
134. J. V. Meharg, J. McGowan-Jordan, A. Charles, J. T. Parmelees, M. V. Cutaia, and S. Rounds. Hydrogen peroxide stimulates sodium-potassium pump activity in cultured pulmonary artery endothelial cells. Am. J. Physiol. 265:L613-L621 (1993).
135. J. Varani, and P. A. Ward. Mechanisms of endothelial cell injury in acute inflammation. Shock 2:311-319 (1994).
136. D. W. Granger, and P. Kubes. The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J. Leukoc. Biol. 55:662-675 (1994).
137. M. C. Carreras, G. A. Pargament, S. D. Catz, J. J. Poderoso, and A. Boveris. Kinetics of nitric oxide and hydrogen peroxide production and formation of peroxynitrite during the respiratory burst of human neutrophils. FEBS Lett. 341:65-68 (1994).
138. S. J. Weiss. Tissue destruction by neutrophils. N. Engl. J. Med. 320:365-376 (1989).
139. N. M. Domigan, T. S. Charlton, M. W. Duncan, C. C. Winterbourn, and A. J. Kettle. Chlorination of tyrosyl residues in peptides by myeloperoxidase and human neutrophils. J. Biol. Chem. 270:16542-16548 (1995).
140. A. van der Vliet, M. L. Hu, C. A. O'Neill, C. E. Cross, B. Halliwell. Interactions of human blood plasma with hydrogen peroxide and hypochlorous acid. J. Lab. Clin. Med. 1124:701-707 (1994).
141. R. Ross. The pathogenesis of atherosclerosis, a perspective for the 1990s. Nature 362:801-809 (1993).
142. Y. Ohara, T. E. Peterson and D. G. Harrison. Hypercholesterolemia increases endothelial superoxide anion production. J. Clin. Invest. 91:2541-2551 (1993).
143. J. W. Heinecke, H. Rosen, L. A. Suzuki, and A. Chait. The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. J. Biol. Chem. 262:10098-10103 (1987).
144. C. P. Sparrow, and J. Olszewski. Cellular oxidation of low-density lipoprotein is caused by thiol production in media containing transition metals. J. Lipid Res. 34:1219-1228 (1993).
145. A. Graham, J. L. Wood, V. J. O'Leary, and D. Stone. Human (THP-1) macrophages oxidize LDL by a thiol-dependent mechanism. Free Rad. Res. 21:295-308 (1994).
146. F. Liao, J. A. Berliner, M. Mehrabian, M. Navab, L. L. Demer, A. J. Lusis, and A. M. Fogelman. Minimally modified low density lipoprotein is biologically active in vivo in mice. J. Clin. Invest. 87:2253-2257 (1991).
147. M. E. Rosenfeld. Oxidized LDL affects multiple atherogenic cellular responses. Circulation 83:2137-2140 (1991).
148. T. Collins. Endothelial nuclear factor -kB and the initiation of the atherosclerotic lesion. Lab. Invest. 68:499-508 (1993).
149. A. J. Lusis, and M. Navab. Lipoprotein oxidation and gene expression in the artery wall. Biochem. Pharmacol. 46:2119-2126 (1993).
150. M. A. Warso, and W. E. M. Lands. Lipid peroxidation in relation to prostacyclin and thromboxane physiology and pathophysiology. Br. Med. Bull. 39:277-280 (1983).
151. J. A. Holland, K. A. Pritchard, W. J. Rogers, and M. B. Stemerman. Perturbation of cultured human endothelial cells by atherogenic levels of low density lipoprotein. Am. J. Pathol. 132:474-478 (1988).
152. M. Yokode, T. Kita, Y. Kikawa, T. Ogorochi, S. Narumiya, and C. Kawai. Stimulated arachidonate metabolism during foam cell transformation of mouse peritoneal macrophages with oxidized low density lipoprotein. J. Clin. Invest. 81:720-729 (1988).
153. C. A. Smith, M. J. Mitchinson, O. I. Aruoma, and B. Halliwell. Stimulation of lipid peroxidation and hydroxyl radical generation by the contents of human atherosclerotic lesions. Biochem. J. 286:901-905 (1992).
154. C. J. Lamb, M. J. Mitchinson, and D. S. Leake. Transition metal ions within human atherosclerotic lesions can catalyze the oxidation of low density lipoprotein by macrophages. FEBS Lett. 374:12-16 (1995).
155. J. Swain, and J. M. C. Gutteridge. Pro-oxidant iron and copper, with ferroxidase and xanthine oxidase activities, in human atherosclerotic material. FEBS Lett. 368:513-515 (1995).
156. H. F. Hoff, and J. O'Neill. Extracts of human atherosclerotic lesions can modify low density lipoproteins leading to enhanced uptake by macrophages. Atherosclerosis 70:29-41 (1988).
157. P. J. Evans, C. Smith, M. J. Mitchinson, and B. Halliwell: Metal ion release from mechanically-disrupted human arterial wall. Implications for the development of atherosclerosis. Free Rad. Res. 23:465-469 1995.
158. A. Graham, N. Hogg, B. Kalyanaraman, V. O'Leary, V. Darley-Usmar, and S. Moncada. Peroxynitrite modification of low-density lipoprotein leads to recognition by the macrophage scavenger receptor. FEBS Lett. 330:181-185 (1993).
159. J. S. Beckman, Y. Z. Ye, P. G. Anderson, J. Chen, M. A. Accavatti, M. M. Tarpey, and C. R. White. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol. Chem. Hoppe Seyler 375:81-88 (1994).
160. J. Kanner, S. Harel, and R. Granit. Nitric oxide as an antioxidant. Arch. Biochem. Biophys. 289:130-136 (1991).
161. G. Dee, C. Rice-Evans, S. Obeyesekara et al. The modulation of ferryl myoglobin formation and its oxidative effects on low density lipoproteins by nitric oxides. FEBS Lett. 294:38-42 (1991).
162. D. A. Wink, I. Hanbauer, M. C. Krishna, W. De Gratt, J. Gamson, and J. B. Mitchell. Nitric oxide protects against cellular damage and cytoxicity from reactive oxygen species. Proc. Natl. Acad. Sci. USA 90:9813-9817 (1993).
163. B. Halliwell. Superoxide, iron, vascular endothelium and reperfusion injury. Free Rad. Res. Commun. 5:315-318 (1989).
164. A. van der Vliet, D. Smith, C. A. O'Neill, H. Kaur, V. Darley-Usmar, C. E. Cross, and B. Halliwell. Interactions of peroxynitrite with human plasma and its constituents: oxidative damage and antioxidant depletion. Biochem. J. 303:295-301 (1994).
165. S. Padmaja, and R. E. Huie. The reaction of nitric oxide with organic peroxyl radicals. Biochem. Biophys. Res. Commun. 195:539-544 (1993).
166. N. Hogg, B. Kalyanaraman, J. Joseph, A. Struck, and S. Parthasarathy. Inhibition of low-density lipoprotein oxidation by nitric oxide. FEBS Lett. 334:170-174 (1993).
167. J. Gaboury, R. C. Woodman, D. N. Granger, P. Reinhardt, and P. Kubes. Nitric oxide prevents leukocyte adherence: role of superoxide. Am. J. Physiol. 265:H862-H867 (1993).
168. H. Rubbo, R. Radi, M. Trujillo, R. Teilen, B. Kalyanaraman, S. Barnes, M. Kirk, and B. A. Freeman. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. J. Biol. Chem. 269:26066-26075 (1994).
169. A. Daugherty, J. L. Dunn, D. L. Raten, and J. W. Heinecke. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94:437-444 (1994).
170. M. I. Savenkova, D. M. Mueller, and J. W. Heinecke. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein. J. Biol. Chem. 269:20394-20400 (1994).
171. J. Eiserich, J. Butler, A. van der Vliet, C. E. Cross, and B. Halliwell. Nitric oxide rapidly scavenges tyrosine and tryptophan radicals. Biochem. J. 310:745-749 (1995).
172. M. T. Yates, L. E. Lambert, J. P. Whitten et al. A protective role for nitric oxide in the oxidative modification of low density lipoproteins by mouse macrophages. FEBS Lett. 309:135-138 (1992).
173. W. Jessup, D. Mohr, S. P. Gieseg, R. T. Dean, and R. Stocker. The participation of nitric oxide in cell free- and its restriction of macrophage-mediated oxidation of low density lipoprotein. Biochim. Biophys. Acta 1880:73-82 (1992).
174. U. Malo-Ranta, S. Ylä-Herttuala, T. Metsä-Ketelä, O. Jaakkola, E. Moilanen. P. Vuorinen, and T. Nikkari. Nitric oxide donor GEA 3162 inhibits endothelial cell-mediated oxidation of low density lipoprotein. FEBS Lett. 337:179-183 (1994).
175. W. C. Tarry, and R. G. Makhoul. L-arginine improves endothelium-dependent vasorelaxation and reduces intimai hyperplasia after balloon angioplasty. Arteriosclerosis Thrombosis 14:938-943 (1994).
176. J. P. Cooke, A. H. Singer, P. Tsao, P. Zera, R. A. Rowan, and M. E. Billingham. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J. Clin. Invest. 90:1168-1172 (1992).
177. H. E. Von der Leyen, G. H. Gibbons, Y. Morishita, N. P. Lewis, L. Zhang, M. Nakajima, Y. Kaneda, J. P. Cooke, and V. J. Dzau. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc. Natl. Acad. Sci. USA 92:1137-1141 (1995).
178. V. Darley-Usmar, H. Wiseman, and B. Halliwell. Nitric oxide and oxygen radicals: a question of balance. FEBS Lett. 369:131-135 (1995).
179. K. M. Naseem, and K. R. Bruckdorfer. Hydrogen peroxide at low concentrations strongly enhances the inhibitory effect of nitric oxide on platelets. Biochem. J. 310:149-153 (1995).
180. R. W. Alexander. Hypertension and the pathogenesis of atherosclerosis. Hypertension 25:155-161 (1995).
181. D. Steinberg. Clinical trials of antioxidants in atherosclerosis: are we doing the right thing? Lancet 346:36-38 (1995).
182. M. A. Marietta. Approaches to selective inhibition of nitric oxide synthase. J. Med. Chem. 37:1899-1907 (1994).
183. E. S. Furfine, H. F. Harmon, J. E. Paith, R. G. Knowles, M. Salter, R. J. Kiff, C. Durthy, R. Hazelwood, J. A. Oplinger, and E. P. Garvey. Potent and selective inhibition of human nitric oxide synthases. Selective inhibition of neuronal nitric oxide synthase by S-methyl-L-thiocitrulline and S-ethyl-L-thiocitrulline. J. Biol. Chem. 269:26677-26683 (1994).
184. R. C. Babbedge, P. A. Bland-Ward, S. L. Hart, and P. K. Moore. Inhibition of rat cerebellar nitric oxide synthase by 7-nitro indazole and related substituted indazoles. Br. J. Pharmacol. 110:225-228 (1993).
185. A. Petros, G. Lamb, A. Leone, S. Moncada, D. Bennett and P. Valance. Effects of NO synthase inhibitors in humans with septic shock. Cardinvasc. Res. 28:343-339 (1994).
186. T. Munzel, H. Sayegh, B. A. Freeman, M. M. Tarpey, and D. G. Harrison. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. J. Clin. Invest. 95:187-194 (1995).
187. M. Radomski, D. Rees, A. Dutra and S. Moncada. S-nitrosoglutathione inhibits platelet activation in vitro and in vivo. Br. J. Pharmacol. 107:745-749 (1992).
188. J. R. Connor, P. T. Manning, S. L. Settle, W. M. Moore, G. M. Jerome, R. K. Webber, F. S. Tjoengand M. G. Currie. Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase. Eur. J. Pharm. 273:15-24 (1995).
189. H. Drexler, A. M. Zeiher, K. Meinzer and H. Just. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaernic patients by L-arginine. Lancet 338:1546-1550 (1991).
190. M. Inoue, N. Watanabe, Y. Morino, Y. Tanaka, T. Amachi, and J. Sasaki. Inhibition of oxygen toxicity by targeting superoxide dismutase to endothelial cell surface. FEBS Lett. 269:89-92 (1990).
191. T. P. Kasten, S. L. Settle, T. P. Misko, D. P. Riley, R. H. Weiss, M. G. Currie, and G. A. Nickols. Potentiation of nitric oxide-mediated vascular relaxation by SC52608, a superoxide dismutase mimic. Proc. Soc. Exp. Biol. Med. 208:170-177 (1995).
192. C. R. White, T. A. Brock, L. Y. Chang, J. Crapo, P. Briscoe, D. Ku, W. A. Bradley, S. H. Gianturco, J. Gore, B. A. Freeman, and M. M. Tarpey. Superoxide and peroxynitrite in atherosclerosis. Proc. Natl. Acad. Sci. USA 91:1044-1048 (1994).
193. T. E. Carew, D. C. Schwenke and D. Steinberg. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Proc. Natl. Acad. Sci. USA 84:7725-7729 (1987).
194. V. J. O'Leary, T. Tilling, G. Fleetwood, D. Stone and V. M. Darley-Usmar. The resistance of low density lipoprotein to oxidation promoted by copper and its use as an index of antioxidant therapy. Atherosclerosis 119:169-179 (1995).